| HOME >> BIOLOGY >> TECHNOLOGY |
Interest income 497 1,040 1,303 1,984
Other than temporary
decline in value of
investments (3,052) - (3,055) -
Other income (expense) (4) 19 9 20
Income (loss) before
income tax provision (4,879) 11,910 (5,949) 8,411
Income tax provision - (833) - (663)
Net income (loss) $(4,879) $11,077 $(5,949) $7,748
Net income (loss) per
common share:
Basic $(0.08) $0.19 $(0.10) $0.14
Diluted $(0.08) $0.19 $(0.10) $0.14
Weighted average shares
outstanding:
Basic 57,542 57,010 57,531 56,237
Diluted 57,542 58,143 57,531 57,087
SUPERGEN, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
June 30, December 31,
2008 2007
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $76,344 $78,055
Marketable securities 8,483 9,375
Accounts receivable, net 3 71
Accounts receivable from Mayne Pharma 11 58
Prepaid expenses and other current assets 1,288 728
Total current assets 86,129 88,287
Marketable securities, non-current 2,733 3,419
Property, plant a
'/>"/>
| SOURCE SuperGen, Inc. Copyright©2008 PR Newswire. All rights reserved |